0001832415-23-000004.txt : 20230811 0001832415-23-000004.hdr.sgml : 20230811 20230811160137 ACCESSION NUMBER: 0001832415-23-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 EFFECTIVENESS DATE: 20230811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Better Therapeutics, Inc. CENTRAL INDEX KEY: 0001832415 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489531 FILM NUMBER: 231163888 BUSINESS ADDRESS: STREET 1: 548 MARKET ST. #49404 CITY: SAN FRANCISCO STATE: CA ZIP: 94101 BUSINESS PHONE: 415-887-2311 MAIL ADDRESS: STREET 1: 548 MARKET ST. #49404 CITY: SAN FRANCISCO STATE: CA ZIP: 94101 FORMER COMPANY: FORMER CONFORMED NAME: Mountain Crest Acquisition Corp II DATE OF NAME CHANGE: 20201116 D 1 primary_doc.xml X0708 D LIVE 0001832415 Better Therapeutics, Inc. 548 MARKET ST. #49404 SAN FRANCISCO CA CALIFORNIA 94101 (415) 887-2311 DELAWARE Mountain Crest Acquisition Corp II Corporation true 2020 Frank Karbe 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Director David Perry 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Director Mark Berman 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Kristin Wynholds 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Mark Heinen 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Executive Officer Richard Carmona c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Andrew Armanino c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Risa Lavizzo-Mourey c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Geoffrey Parker c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Elder Granger c/o Better Therapeutics, Inc. 548 Market St. #49404 San Francisco CA CALIFORNIA 94104 Director Biotechnology Decline to Disclose 06b false 2023-07-27 false true false 0 Chardan Capital Markets LLC 120128 None None 17 State Street, Suite 2130 New York NY NEW YORK 10004 AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS NJ NEW JERSEY NY NEW YORK TX TEXAS WA WASHINGTON true Titan Partners Group LLC, a division of American Capital Partners, LLC 44656 None None 7 World Trade Center, 46th Floor New York NY NEW YORK 10007 AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS NJ NEW JERSEY NY NEW YORK TX TEXAS WA WASHINGTON true 2114998 2114998 0 Private placement of 2,897,654 shares of common stock at a price of $0.7299 per share. false 10 126900 0 0 false Better Therapeutics, Inc. /s/ Mark Heinen Mark Heinen Chief Financial Officer 2023-08-11